"What" Series

What is CRA in Life Sciences?

26 September 2023
2 min read

The full name is Clinical Research Assistant, who assists the principal investigator in implementing clinical trials according to the trial protocol and GCP. 

The CRA is the main contact person between the sponsor and the investigator. The number of CRAs and the frequency of visits depend on the complexity of the clinical trial and the number of medical institutions involved in the trial. CRAs should have appropriate medical, pharmaceutical, or related professional qualifications and undergo necessary training, be familiar with drug management-related regulations, be familiar with pre-clinical and clinical information about the investigational drug, and clinical trial protocols and related documents.

The purpose of their monitoring is to ensure that the rights of subjects in clinical trials are protected, that the data of trial records and reports are accurate, complete, and correct, and that the trials follow the approved protocols and relevant regulations.

Analysis on the Clinical Research Progress of cholesterol drug
Analysis on the Clinical Research Progress of cholesterol drug
26 September 2023
Cholesterol, also known as cholesterin, is a derivative of polycyclic hydrocarbon, widely present in animal bodies, especially abundant in brain and neural tissues.
Read →
What is a CRO in Life Sciences?
"What" Series
2 min read
What is a CRO in Life Sciences?
26 September 2023
The full name is Contract Research Organization, which is a contract outsourcing service organization for new drug research and development.
Read →
Analysis on the Research Progress of IL-6 inhibitors
Analysis on the Research Progress of IL-6 inhibitors
26 September 2023
Interleukin-6 (IL-6) is a 26-kDa secretory protein composed of 184 amino acids and two N-glycosylation sites, as well as four cysteine residues in the mature IL-6.
Read →
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
Latest Hotspot
3 min read
Orchard Therapeutics Declares Approval of Biologics License Application for OTL-200 pertaining to MLD
26 September 2023
Orchard Therapeutics, a renowned leader in gene therapy worldwide, reported that the U.S. FDA has approved the submission of their BLA for OTL-200.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.